07:00 , Oct 15, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Glycinamide ribonucleotide formyltransferase (GARFT); folate receptor 1 (FOLR1; FR-α); FOLR2 (FR-β); solute carrier family 46 folate transporter m

Cancer INDICATION: Cancer Mouse and cell studies identified an inhibitor of GARFT, FOLR1, FOLR2 and SLC46A1 that could help treat folate receptor-expressing cancers. Chemical synthesis and in vitro testing of pyrimidine antifolate thienoyl analogs identified a compound...
07:00 , May 7, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer ...